Skip to the page

Data / Drug companies / Miconazole nitrate 2% antifungal

Miconazole nitrate 2% antifungal: 2 companies and 3 products in the FDA NDC directory

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Miconazole nitrate 2% antifungal is listed in the FDA National Drug Code Directory by 2 companies, with 3 products in commercial distribution. 0 of the products (0.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are cream; liquid, and the newest product started marketing on June 11, 2026.

The request: Get every company that lists miconazole nitrate 2% antifungal in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Companies listing it
2
Products
3
Generic (ANDA) products
0 (0.0%)
Application numbers
1
Routes
Topical
Brand names
Lasolex Al, Inlifay Antifungal, Lasolex Ac
openFDA record search
api.fda.gov

Companies that list miconazole nitrate 2% antifungal

Ranked by number of products. Finished drugs in commercial distribution.

CompanyProductsMain dosage formsMain marketing categoryNewest product started
PureTek Corporation2liquid; creamOver the counter monograph drugsJune 11, 2026
Jiangxi Yudexi Pharmaceutical Co., LTD1creamOver the counter monograph drugsFebruary 11, 2026

Dosage forms

Dosage formProductsShare
Cream266.7%
Liquid133.3%

Marketing categories

Marketing categoryProductsShare
Over the counter monograph drugs3100%

Pharmacologic classes

ClassProducts
Azole Antifungal3

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.